Transgender youth, teens more likely to have sleep disorders

Transgender and gender-nonconforming youth are four times more likely to have a sleep disorder compared to cisgender youth, a Michigan Medicine-led study finds. Researchers also found that those who pursued gender-affirming therapy were half as likely to have any sleep disorder than transgender individuals who did not pursue the therapy, suggesting a possible protective effect.

Gender Affirmation Treatment Delivery Route May Affect Heart Health

Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.

Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Transgender college students report higher rates of sleep, mental health concerns

Transgender individuals are more likely to experience discrimination, isolation, and lack of social support. This, along with negative psychosocial challenges, such as being denied access to gender-neutral restrooms, combined with being a college student, and you have what associate professor of neurology, Shelley Hershner M.D., calls “a perfect storm” that can contribute to sleep disorders and other mental health concerns.

Endocrine Society opposes Florida Department of Health policy on gender dysphoria treatment for children and adolescents

The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.

Endocrine Society and partners to intervene in U.K. transgender medicine court appeal

The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal suppression.

Discriminatory policies threaten care for transgender, gender diverse individuals

The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism.

Endocrine Society opposes Administration’s effort to roll back protections for transgender health

The Endocrine Society is alarmed by the Administration’s proposed rule to roll back protections for transgender individuals and narrow the scope of the Affordable Care Act (ACA), especially during the COVID-19 pandemic, when everyone needs access to health care. The Society calls on the Administration to maintain access to care protections for all, particularly vulnerable populations.